Literature DB >> 18028322

KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.

Jian-Min Yang1, Zhi-Hong Peng, Sui-Hai Si, Wei-Wen Liu, Yuan-Hui Luo, Zai-Yuan Ye.   

Abstract

BACKGROUND: Downregulation of KAI1 gene expression has been found in many types of cancer cells and is closely related to cancer invasion and metastasis. This study was aimed at investigating the effects and possible underlying mechanisms of KAI1 gene on invasion and metastasis of human hepatocellular carcinoma (HCC).
METHODS: The invasive ability, visco-elastic properties and cell adhesion forces were analysed in different HCC cells originating from the MHCC97-H cell line transfected with either the sense or the antisense KAI1 expression plasmid. Tumuorigenicity, metastatic abilities, extracellular matrix (ECM) and intercellular adhesion molecule-1 (ICAM-1) expression were also evaluated in the nude mouse models of the xenografted and orthotopic liver cancer cells.
RESULTS: Compared with their parental cells, in the HCC cells transfected with the sense KAI1 gene, the invasive ability in vitro was significantly decreased (P<0.01); the cellular elastic coefficients K(1), K(2) and mu were significantly higher (P<0.05); the cells adhesion forces to fibronectin were significantly lower (P<0.01). The sense KAI1 gene transfection into the cancer cells also inhibited their invasion and lung metastasis in the orthotopic liver cancer nude mice. However, the opposite changes were observed in the HCC cells transfected with the antisense KAI1 gene. KAI1 gene transfection also affected ECM and ICAM-1 expression in the transplanted liver cancer.
CONCLUSION: The KAI1 gene plays an important role in the invasion and metastasis of human HCC and its upregulation in HCC cells suppresses their invasive and metastatic abilities. KAI1 gene functioned as a metastasis inhibitor by regulating the HCC cell biophysical behaviours including aggregation, adhesion, motility and visco-elastic properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028322     DOI: 10.1111/j.1478-3231.2007.01620.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

Review 1.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

2.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

Review 3.  Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  FEBS Lett       Date:  2011-08-27       Impact factor: 4.124

4.  Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro.

Authors:  Hui Yan; Xunda Ji; Jing Li; Lei Zhang; Peiquan Zhao
Journal:  Oncol Lett       Date:  2016-12-16       Impact factor: 2.967

5.  Double lethal effects of fusion gene of wild-type p53 and JunB on hepatocellular carcinoma cells.

Authors:  Cheng Guo; Qingguang Liu; Lei Zhang; Xue Yang; Tao Song; Yingmin Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10

6.  Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.

Authors:  Deshui Jia; Ying Jing; Zhenfeng Zhang; Li Liu; Jie Ding; Fangyu Zhao; Chao Ge; Qifeng Wang; Taoyang Chen; Ming Yao; Jinjun Li; Jianren Gu; Xianghuo He
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

7.  Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.

Authors:  Julia Miller; Tobias F Dreyer; Anne Sophie Bächer; Eva-Kathrin Sinner; Christine Heinrich; Anke Benge; Eva Gross; Sarah Preis; Jan Rother; Anthony Roberts; Gabriele Nelles; Tzenka Miteva; Ute Reuning
Journal:  Oncotarget       Date:  2018-01-05

8.  The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.

Authors:  Jaeseob Lee; Hee-Jung Byun; Moon-Sung Lee; Young-June Jin; Dooil Jeoung; Young-Myeong Kim; Hansoo Lee
Journal:  Oncotarget       Date:  2017-01-03

9.  Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinoma.

Authors:  Wu Zhang; Cheng Guang Zhao; Hong Yu Sun; Wei E Zheng; Hua Chen
Journal:  Gut Liver       Date:  2014-07-25       Impact factor: 4.519

10.  The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.

Authors:  Jundong Zhu; Chao Liang; Yibo Hua; Chenkui Miao; Jianzhong Zhang; Aiming Xu; Kai Zhao; Shouyong Liu; Ye Tian; Huiyu Dong; Chao Zhang; Pu Li; Shifeng Su; Chao Qin; Zengjun Wang
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.